Why the study?
Do statins reduce the incidence of ventricular arrhythmias in cardiomyopathy patients with an implantable cardioverter defibrillator?
Do statins reduce the incidence of ventricular arrhythmias in cardiomyopathy patients with an implantable cardioverter defibrillator?
Observational evidence suggests statins may possess anti-arrhythmic properties that reduce ventricular arrhythmias in cardiomyopathy patients with ICDs, though randomized trials are needed to confirm this effect.
Answers are grounded in this paper and cite their sources.
May support antiarrhythmic statin effects in cardiomyopathy patients with ICDs; hypothesis-generating and requires randomized confirmation.
BACKGROUND: Recent studies have demonstrated that statins may possess anti-arrhythmic properties in addition to their lipid-lowering effects. METHODS: Studies which reported the association of statins with the incidence of ventricular arrhythmias were identified through a systematic review of the published literature. RESULTS: Statins have been associated with a significant reductions in ventricular arrhythmia in cardiomyopathy patients with an implantable cardioverter defibrillator, although randomized trials have not been completed. CONCLUSIONS: Published data suggests that statins may possess anti-arrhythmic properties that reduce the propensity for ventricular arrhythmias. Most of this data is observational; more randomized, placebo-controlled trials are needed.
No takes yet. Share an insight, caveat, or question.
Abuissa et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: